Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,707Revenue $M4,561Net Margin (%)11.9Z-Score4.3
Enterprise Value $M24,786EPS $1.0Operating Margin %19.6F-Score6
P/E(ttm))38.7Cash Flow Per Share $0Pre-tax Margin (%)16.8Higher ROA y-yY
Price/Book15.910-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsN
Price/Sales4.65-y EBITDA Growth Rate %27.3Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %27.6ROA % (ttm)8.7Higher Current Ratio y-yY
Dividend Yield %0.7Insider Buy (3m)0ROE % (ttm)51.2Less Shares Outstanding y-yN
Payout Ratio %25.0Shares Outstanding M501ROI % (ttm)8.4Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZTSBill Ackman 2014-09-30 Buy 1.5%$31.79 - $37.2
($34.27)
$ 43.3226%New holding, 5536862 sh.5,536,862
ZTSJoel Greenblatt 2014-09-30 Sold Out -0.01%$31.79 - $37.2
($34.27)
$ 43.3226%Sold Out0
ZTSJoel Greenblatt 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 43.3241%Reduce -22.04%33,034
ZTSJean-Marie Eveillard 2014-06-30 Reduce-0.12%$28.4 - $32.89
($30.65)
$ 43.3241%Reduce -42.15%2,177,060
ZTSGeorge Soros 2014-03-31 Add0.49%$29.01 - $32.69
($30.64)
$ 43.3241%Add 68.52%4,205,043
ZTSVanguard Health Care Fund 2014-03-31 Add0.16%$29.01 - $32.69
($30.63)
$ 43.3241%Add 23.89%10,421,717
ZTSJoel Greenblatt 2014-03-31 Buy 0.02%$29.01 - $32.69
($30.64)
$ 43.3241%New holding, 42374 sh.42,374
ZTSLee Ainslie 2014-03-31 Sold Out -3.2%$29.01 - $32.69
($30.64)
$ 43.3241%Sold Out0
ZTSJean-Marie Eveillard 2014-03-31 Reduce-0.26%$29.01 - $32.69
($30.64)
$ 43.3241%Reduce -43.39%3,763,386
ZTSLee Ainslie 2013-12-31 Add3.05%$31.04 - $33.22
($31.88)
$ 43.3236%Add 2021.15%7,635,025
ZTSGeorge Soros 2013-12-31 Add0.24%$31.04 - $33.22
($31.88)
$ 43.3236%Add 54.13%2,495,329
ZTSJean-Marie Eveillard 2013-09-30 Add0.5%$29.15 - $32.72
($30.63)
$ 43.3241%Add 1447.21%5,842,948
ZTSLee Ainslie 2013-09-30 Buy 0.15%$29.15 - $32.72
($30.63)
$ 43.3241%New holding, 359948 sh.359,948
ZTSMario Gabelli 2013-09-30 Add0.04%$29.15 - $32.72
($30.63)
$ 43.3241%Add 350.26%244,760
ZTSRuane Cunniff 2013-09-30 Add0.03%$29.15 - $32.72
($30.63)
$ 43.3241%Add 767.96%173,973
ZTSJohn Keeley 2013-09-30 Add0.02%$29.15 - $32.72
($30.63)
$ 43.3241%Add 95.24%81,519
ZTSGeorge Soros 2013-09-30 Reduce-0.26%$29.15 - $32.72
($30.63)
$ 43.3241%Reduce -32.68%1,619,011
ZTSJoel Greenblatt 2013-09-30 Sold Out -0.04%$29.15 - $32.72
($30.63)
$ 43.3241%Sold Out0
ZTSVanguard Health Care Fund 2013-06-30 Add0.88%$30.19 - $34.26
($32.38)
$ 43.3234%Add 1167.44%8,412,017
ZTSGeorge Soros 2013-06-30 Add0.59%$30.19 - $34.26
($32.38)
$ 43.3234%Add 262.41%2,404,811
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZTS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ZTS Bill Ackman 2014-09-305,536,8621.11.5New Buy
ZTS John Keeley 2014-09-3079,5040.020.06+6.71%
ZTS Robert Olstein 2014-09-30178,0000.040.86
ZTS Vanguard Health Care Fund 2014-09-3010,798,4172.151
ZTS Jean-Marie Eveillard 2014-09-302,174,1620.430.2-0.13%
ZTS Ruane Cunniff 2014-09-30173,3220.030.03-0.14%
ZTS George Soros 2014-09-304,031,7350.81.1-8.09%
ZTS Mario Gabelli 2014-09-30217,9800.040.04-10.29%
ZTS Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.3538.18view
Knupp Catherine A.Executive Vice President 2013-02-06Buy1,000$2666.62view
Chen Heidi C.Executive Vice President 2013-02-06Buy2,500$2666.62view
Beaty Sandra J.Executive Vice President 2013-02-06Buy2,000$2666.62view
STEERE WILLIAM C JRDirector 2013-02-06Buy4,500$2666.62view
Norden GregoryDirector 2013-02-06Buy3,000$2666.62view
SCHULMAN AMY WDirector 2013-02-06Buy5,000$2666.62view
HILL CHARLES HDirector 2013-02-06Buy5,000$2666.62view
Giordano Douglas E.Director 2013-02-06Buy5,000$2666.62view
Germano Geno JDirector 2013-02-06Buy5,000$2666.62view

Press Releases about ZTS :

    Quarterly/Annual Reports about ZTS:

    News about ZTS:

    Articles On GuruFocus.com
    Feeling Good With This Med Company Jan 20 2015 
    2015 - First Half Jan 01 2015 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis Nov 12 2014 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Guru Stocks at 52-Week Lows: HMC, NMR, SDRL, ZTS, BBBY Apr 21 2014 
    Morning Coffee: Widely Held Guru Stocks Near 52-Week Lows Apr 10 2014 
    Morning Coffee: Guru Stocks Near 52-Week Lows Apr 03 2014 
    Guru Stocks at 52-Week Lows: CEO, BCS, HMC, ED, ZTS Apr 01 2014 

    More From Other Websites
    Midday movers: Boeing, Kate Spade, Viacom & more Jan 29 2015
    Top activist plays for 2015 Jan 21 2015
    BUZZ-Indivior: Citi tips spinoff to outperform parent Jan 05 2015
    3 hedge fund predictions for 2015 Dec 31 2014
    Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2014 Financial Results Dec 31 2014
    Zoetis Boosts Dividend After Ackman Raises Stake Dec 17 2014
    Zoetis raises quarterly dividend 15% Dec 17 2014
    ZOETIS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 17 2014
    Zoetis Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increase Dec 17 2014
    Zoetis to Participate in the 33rd Annual J.P. Morgan Healthcare Conference Dec 17 2014
    Livestock products lead Zoetis’ 3Q14 revenue growth Dec 11 2014
    Must-know trends that drive Zoetis’ growth Dec 10 2014
    Zoetis: An attractive business model Dec 10 2014
    Pershing Square takes 8.5% stake in Zoetis Dec 10 2014
    Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO Dec 09 2014
    Bayer Doesn’t Look Ready for Animal Magnetism Dec 05 2014
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014
    Zoetis to Participate in the Bank of America Animal & Dental Health Summit Dec 02 2014
    Jefferies Raises Zoetis Price Target, Says Consolidation Continues To Look Likely Nov 26 2014
    Bayer explores possible sale of diabetes device unit -Bloomberg Nov 24 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK